Recruiting studies: Gastrointestinal Cancer Metastatic

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.
Phase N/A · 1 location(s) · Jules Bordet Institute · NCT07451483 Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC
Phase 3 · 12 location(s) · Sun Yat-sen University · NCT05768503 Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer.
NA · 1 location(s) · Hospices Civils de Lyon · NCT06929013 Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The K
Phase 4 · 1 location(s) · OHSU Knight Cancer Institute · NCT07405086 ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases
Phase N/A · 16 location(s) · GERCOR - Multidisciplinary Oncology Cooperative Group · NCT05787197 SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid T
Phase 1 · 11 location(s) · Qurgen Inc. · NCT06873659 Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT02830724 Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
Phase 2 · 9 location(s) · Rutgers, The State University of New Jersey · NCT05806931 Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal
Phase 2 · 28 location(s) · Gruppo Oncologico del Nord-Ovest · NCT07407465 A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05837767 Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
Phase 2 · 1 location(s) · Beth Israel Deaconess Medical Center · NCT05655949 Identification of Therapeutic Targets in Metastatic Gastric Cancer
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07551440 Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Be
Phase 1 · 13 location(s) · National Cancer Institute (NCI) · NCT06696768 Establishment of a Tumor Bank for Blood Samples
Phase N/A · 6 location(s) · Medical University of Vienna · NCT01763125 A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmaco
Phase 1 · 2 location(s) · Vall d'Hebron Institute of Oncology · NCT07593820 Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07224841 Comparing 18F-FAPI PET-Guided Abdominal Radiotherapy Combined With Second-Line Standard Therapy and Cadonilimab Versus S
Phase 2 · 2 location(s) · Fudan University · NCT07079462 Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Phase 1 · 7 location(s) · Sairopa B.V. · NCT05856981 Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
Phase N/A · 13 location(s) · Chinese Academy of Sciences · NCT05722275 Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatmen
Phase 1/Phase 2 · 49 location(s) · Pfizer · NCT07227012 A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (
Phase 3 · 88 location(s) · Daiichi Sankyo · NCT06644781 Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Phase 1 · 8 location(s) · Orano Med Theranostics, SAS · NCT05283330 GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer
Phase N/A · 15 location(s) · Claus Lindbjerg Andersen · NCT06111105 Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
Phase 2 · 2 location(s) · Ruijin Hospital · NCT07085169 Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
Phase 2 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT03977233 First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Se
Phase 1 · 3 location(s) · Molecure S.A. · NCT05759923 Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metasta
Phase 1/Phase 2 · 4 location(s) · National Cancer Institute (NCI) · NCT06811116 5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.
Phase 1/Phase 2 · 3 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT04689347 A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherap
NA · 1 location(s) · Yale University · NCT07291180 A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colo
Phase 2 · 1 location(s) · Blokhin's Russian Cancer Research Center · NCT06978400

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.